Nan Fung Group Holdings Ltd

Q3 2021 13F Combination Report, Stock Holdings

Signature - Title
Tang Chun Wai Nelson - Director
Location
Kai Tak, Hong Kong
Holdings as of
September 30, 2021
Value $
$312M
Num holdings
28
Date filed
11/15/2021, 04:06 PM
Form type
13F-HR
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included NFH, ILMN, HRMY, KRTX, and SLGC.
Previous filing
Q2 2021 - Sep 22, 2021
Next filing
Q4 2021 - Feb 14, 2022
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q3 compared to 2021 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Tang Chun Wai Nelson Director Central, Hong Kong 11/15/2021

List of Other Managers Reporting for Nan Fung Group Holdings Ltd:

Name Holdings Value Location File Number
Pivotal bioVenture Partners Fund I U.G.P. Ltd San Francisco, CA 028-20631
Pivotal bioVenture Partners Investment Advisor LLC $173M San Francisco, CA 028-20630

Other Included Managers (2):

Num Name Location File Number
1 Pivotal bioVenture Partners Investment Advisor LLC San Francisco, CA 028-20630
2 Pivotal bioVenture Partners Fund I U.G.P. Ltd San Francisco, CA 028-20631